Evoke Pharma Reports First Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Evoke Pharma (EVOK) Misses Q1 EPS by 4c
May 11, 2016 4:57 PM EDTEvoke Pharma (NASDAQ: EVOK) reported Q1 EPS of ($0.45), $0.04 worse than the analyst estimate of ($0.41).
As of March 31, 2016, the Companys cash and cash equivalents were approximately $6.1 million.
For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.
... More


